MV Capital Management’s TherapeuticsMD TXMD Stock Holding History

MV Capital Management’s Portfolio TXMD Stock Details TXMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-40	Closed	-$1K	–	703
2021 Q4	$1K	Hold	40	–	–	﹤0.01%	686
2021 Q3	$1K	Hold	40	–	–	﹤0.01%	709
2021 Q2	$2K	Hold	40	–	–	﹤0.01%	638
2021 Q1	$3K	Hold	40	–	–	﹤0.01%	290
2020 Q4	$2K	Hold	40	–	–	﹤0.01%	291
2020 Q3	$3K	Hold	40	–	–	﹤0.01%	253
2020 Q2	$3K	Hold	40	–	–	﹤0.01%	258
2020 Q1	$2K	Hold	40	–	–	﹤0.01%	311
2019 Q4	$5K	Hold	40	–	–	﹤0.01%	290
2019 Q3	$7K	Hold	40	–	–	﹤0.01%	265
2019 Q2	$5K	Hold	40	–	–	﹤0.01%	285
2019 Q1	$10K	Hold	40	–	–	﹤0.01%	234
2018 Q4	$8K	Hold	40	–	–	﹤0.01%	241
2018 Q3	$13K	Hold	40	–	–	﹤0.01%	229
2018 Q2	$12K	Hold	40	–	–	﹤0.01%	240
2018 Q1	$10K	Hold	40	–	–	﹤0.01%	245
2017 Q4	$12K	Sell	40 -40	-50%	-$11.1K	﹤0.01%	239
2017 Q3	$21K	Buy	+80	New	+$23.1K	0.01%	198

Other funds holding TXMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CWG

C WorldWide Group Copenhagen, Denmark $4.66B AUM 11.67% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

MV Capital Management's TXMD Position: Q1 2022 in Review

MV Capital Management sold out of TherapeuticsMD (TXMD) in Q1 2022, closing a stake of 40 shares — an estimated $1K sold.

MV Capital Management first reported a position in TXMD in Q3 2017 and held it in 18 quarters. The position peaked at $21K in Q3 2017. 124 funds tracked by Wall St. Rank hold TXMD as of Q1 2022.

MV Capital Management reported no remaining TherapeuticsMD position as of Q1 2022 after selling out during the quarter.
MV Capital Management sold 40 TherapeuticsMD shares in Q1 2022, an estimated $1K.
MV Capital Management first reported a position in TherapeuticsMD in Q3 2017 and held it in 18 quarters.
MV Capital Management's TherapeuticsMD position peaked at $21K in Q3 2017.
124 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2022.

Based on MV Capital Management's 13F filing for Q1 2022, filed 9 May 2022.